等待开盘 05-19 09:30:00 美东时间
+0.410
+3.19%
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Citigroup analyst Steven Enders maintains Vertex (NASDAQ:VERX) with a Neutral and raises the price target from $15 to $16.
05-09 04:37
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
华盛资讯5月8日讯,Vertex, Inc. Class A公布2026财年Q1业绩,公司Q1营收1.97亿美元,同比增长11.1%,归母净利润亏损0.03亿美元,由盈转亏。
05-08 09:51
华盛资讯5月7日讯,Vertex, Inc. Class A公布2026财年Q1业绩,公司Q1营收1.97亿美元,同比增长11.3%,归母净利润亏损0.03亿美元,由盈转亏。
05-07 19:37
Vertex (NASDAQ:VERX) sees Q2 sales of $200.000 million-$204.000 million vs $203.133 million analyst estimate.
05-07 19:09
Vertex (NASDAQ:VERX) affirms FY2026 sales outlook from $823.500 million-$831.500 million to $823.500 million-$831.500 million vs $827.161 million estimate.
05-07 19:08
Vertex (NASDAQ:VERX) reported quarterly earnings of $0.17 per share which met the analyst consensus estimate. This is a 13.33 percent increase over earnings of $0.15 per share from the same period last year. The company
05-07 19:08
Shares software companies are trading higher following Q1 financial results by ...
05-02 01:12
Shares of companies in the broader software sector are trading lower amid a pul...
04-24 02:46